BALB/c, C57BL/6 (B6) were purchased from the Beijing Laboratory Animal Research Center (Beijing, China). The myeloid -specific mTOR conditional knockout mice (LyzsCre-mTORloxp/loxp) and myeloid cell-specific rictor conditional knockout mice (LyzsCre-rictorloxp/loxp) under C57BL/6 genetic background were obtained by crossing mTORloxp/loxp mice and rictorloxp/loxp mice with mice expressing Cre recombinase under the control of the Lysozyme promoter (Lyzs-Cre) respectively25,33. Lyzs-Cre-negative, mTORloxp/loxp littermates served as the wild-type (WT) control. Six-to-8-week-old mice (male and female) were usually used for the in vitro experiments. mTORloxp/loxp mice were kindly provided by Dr Zhongzhou Yang from Center of Model Animal Research at Nanjing University, China. Lyzs-Cre mice were kindly offered by Dr. Lianfeng Zhang, Key Laboratory of Human Diseases Comparative Medicine, Ministry of Health; Institute of Laboratory Animal Science, CAMS & PUMC. Primers used to identify genetically modified mice are described previously25,33. All animal experiments were performed in accordance with the institutional guidelines and approval of the Animal Ethics Committee of the Institute of Zoology, Beijing, China.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.